These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 27365404)
61. AXL Knock-Out in SNU475 Hepatocellular Carcinoma Cells Provides Evidence for Lethal Effect Associated with G2 Arrest and Polyploidization. Batur T; Argundogan A; Keles U; Mutlu Z; Alotaibi H; Senturk S; Ozturk M Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948046 [TBL] [Abstract][Full Text] [Related]
62. TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis. Chyuan IT; Tsai HF; Wu CS; Sung CC; Hsu PN Front Immunol; 2018; 9():15. PubMed ID: 29403497 [TBL] [Abstract][Full Text] [Related]
63. Gas6 inhibits apoptosis in vascular smooth muscle: role of Axl kinase and Akt. Melaragno MG; Cavet ME; Yan C; Tai LK; Jin ZG; Haendeler J; Berk BC J Mol Cell Cardiol; 2004 Oct; 37(4):881-7. PubMed ID: 15380678 [TBL] [Abstract][Full Text] [Related]
64. Axl is essential for VEGF-A-dependent activation of PI3K/Akt. Ruan GX; Kazlauskas A EMBO J; 2012 Apr; 31(7):1692-703. PubMed ID: 22327215 [TBL] [Abstract][Full Text] [Related]
65. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities. Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G Elife; 2014 Sep; 3():. PubMed ID: 25265470 [TBL] [Abstract][Full Text] [Related]
66. Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells. Cho CY; Huang JS; Shiah SG; Chung SY; Lay JD; Yang YY; Lai GM; Cheng AL; Chen LT; Chuang SE RNA; 2016 Feb; 22(2):303-15. PubMed ID: 26667302 [TBL] [Abstract][Full Text] [Related]
67. Retinal self-antigen induces a predominantly Th1 effector response in Axl and Mertk double-knockout mice. Ye F; Han L; Lu Q; Dong W; Chen Z; Shao H; Kaplan HJ; Li Q; Lu Q J Immunol; 2011 Oct; 187(8):4178-86. PubMed ID: 21918185 [TBL] [Abstract][Full Text] [Related]
68. Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer. Quinn JM; Greenwade MM; Palisoul ML; Opara G; Massad K; Guo L; Zhao P; Beck-Noia H; Hagemann IS; Hagemann AR; McCourt CK; Thaker PH; Powell MA; Mutch DG; Fuh KC Mol Cancer Ther; 2019 Feb; 18(2):389-398. PubMed ID: 30478151 [TBL] [Abstract][Full Text] [Related]
69. Inhibition of Mer and Axl receptor tyrosine kinases leads to increased apoptosis and improved chemosensitivity in human neuroblastoma. Li Y; Wang X; Bi S; Zhao K; Yu C Biochem Biophys Res Commun; 2015 Feb; 457(3):461-6. PubMed ID: 25596315 [TBL] [Abstract][Full Text] [Related]
70. Axl-gas6 interaction counteracts E1A-mediated cell growth suppression and proapoptotic activity. Lee WP; Liao Y; Robinson D; Kung HJ; Liu ET; Hung MC Mol Cell Biol; 1999 Dec; 19(12):8075-82. PubMed ID: 10567533 [TBL] [Abstract][Full Text] [Related]
71. Kinome-wide shRNA screen identifies the receptor tyrosine kinase AXL as a key regulator for mesenchymal glioblastoma stem-like cells. Cheng P; Phillips E; Kim SH; Taylor D; Hielscher T; Puccio L; Hjelmeland AB; Lichter P; Nakano I; Goidts V Stem Cell Reports; 2015 May; 4(5):899-913. PubMed ID: 25921812 [TBL] [Abstract][Full Text] [Related]
72. Glycoxidised LDL induced the upregulation of Axl receptor tyrosine kinase and its ligand in mouse mesangial cells. Kim YS; Jung DH; Sohn E; Kim J; Kim JS PLoS One; 2012; 7(11):e50297. PubMed ID: 23226259 [TBL] [Abstract][Full Text] [Related]
73. The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma. Hector A; Montgomery EA; Karikari C; Canto M; Dunbar KB; Wang JS; Feldmann G; Hong SM; Haffner MC; Meeker AK; Holland SJ; Yu J; Heckrodt TJ; Zhang J; Ding P; Goff D; Singh R; Roa JC; Marimuthu A; Riggins GJ; Eshleman JR; Nelkin BD; Pandey A; Maitra A Cancer Biol Ther; 2010 Nov; 10(10):1009-18. PubMed ID: 20818175 [TBL] [Abstract][Full Text] [Related]
74. [Expression of AXL enhances docetaxel-resistance of prostate cancer cells]. Lin JZ; Zhu JG; Wu HF; Li JM; DE W; Wang ZJ Zhonghua Nan Ke Xue; 2017 Apr; 23(4):302-308. PubMed ID: 29714413 [TBL] [Abstract][Full Text] [Related]